Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.46), $0.24 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $3.13 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.